Shares of GoodRx Holdings (GDRX) are jumping Thursday as the company posted its fourth quarter earnings, revealing revenue increased by 7% to $196.6 million. The company also issued full-year guidance for 2024 that beat Wall Street expectations. These developments come after the company announced a new stock buyback program valued at $450 million. GoodRx CEO Scott Wagner joins the Live show alongside Yahoo Finance Reporter Anjalee Khemlani to discuss the company's initiatives with retail pharmacy and insurance partners. Wagner explains how GoodRx fits into the rush of industry innovation, particularly around AI: "We're working really closely with...not just our retail pharmacy counter partners but the industry in general to really add tech benefit to the flow of a prescription, which is all designed around people, patients, which, how do I not only get that prescription medication but have the right point of affordability? So, there's connection from your doctor's office to the flow of the script to your, frankly, insurance plan to retail. That's one of the big things and big advantages that we provide. Relative to AI, there's a heck of a lot of immediate opportunity in that pricing benefit that we're already working on and leading the industry on." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino

Read more --->